TITLE

GnRH agonist for triggering of final oocyte maturation: time for a change of practice?

AUTHOR(S)
Humaidan, P.; Kol, S.; Papanikolaou, EG.
PUB. DATE
July 2011
SOURCE
Human Reproduction Update;Jul2011, Vol. 17 Issue 4, p510
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND GnRH agonist (GnRHa) triggering has been shown to significantly reduce the occurrence of ovarian hyperstimulation syndrome (OHSS) compared with hCG triggering; however, initially a poor reproductive outcome was reported after GnRHa triggering, due to an apparently uncorrectable luteal phase deficiency. Therefore, the challenge has been to rescue the luteal phase. Studies now report a luteal phase rescue, with a reproductive outcome comparable to that seen after hCG triggering. METHODS This narrative review is based on expert presentations and subsequent group discussions supplemented with publications from literature searches and the authors’ knowledge. Moreover, randomized controlled trials (RCTs) were identified and analysed either in fresh IVF cycles with embryo transfer (ET), oocyte donation cycles or cycles without ET; risk differences were calculated regarding pregnancy rate and OHSS rate. RESULTS In fresh IVF cycles with ET (9 RCTs) no OHSS was reported after GnRHa triggering [0% incidence in the GnRHa group: risk difference 5% (with 95% CI: −0.07 to 0.02)]. Importantly, the delivery rate improved significantly after modified luteal support [6% risk difference in favour of the HCG group (95% CI: −0.14 to 0.2)] when compared with initial studies with conventional luteal support [18% risk difference (95% CI: −0.36 to 0.01)]. In oocyte donation cycles (4 RCTs) the OHSS incidence is 0% [10% risk difference (95% CI: 0.02–0.40)]. CONCLUSIONS GnRHa triggering is a valid alternative to hCG triggering, resulting in an elimination of OHSS. After modified luteal support there is now a non-significant difference of 6% in delivery rate in favour of hCG triggering.
ACCESSION #
61150917

 

Related Articles

  • HCG: Is it the Best Choice for Ovulation Triggering? Humaidan, Peter; Bodri, Daniel; Papanikolaou, Evangelos G.; Kol, Shahar // Open Reproductive Science Journal;2012, Vol. 4, p1 

    With the increasing use of gonadotropin releasing hormone antagonist protocols, it has become an option to trigger ovulation with gonadotropin releasing hormone agonist which has several advantages over human chorionic gonadotropin triggering; among those an elimination or reduction in ovarian...

  • GnRH antagonists are safer than agonists: an update of a Cochrane review. Al-Inany, Hesham G.; Youssef, Mohamed A.F.M.; Aboulghar, Mohamed; Broekmans, Frank; Sterrenburg, Monique; Smit, Janine; Abou-Setta, Ahmed M. // Human Reproduction Update;Jul2011, Vol. 17 Issue 4, p435 

    No abstract available.

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

  • GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Kol, Shahar; Humaidan, Peter; Itskovitz-Eldor, Joseph // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2874 

    BACKGROUND It is now well established that a GnRH agonist (GnRHa) ovulation trigger completely prevents ovarian hyperstimulation syndrome. However, early studies, using conventional luteal support, showed inferior clinical results following a GnRHa trigger compared with a conventional hCG...

  • Benefits of luteinizing hormone activity in ovarian stimulation for IVF. Venetis, C. A; Kolibianakis, E. M.; Tarlatzi, T. B.; Tarlatzis, B. C. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;2009 Supplement 2, Vol. 18 Issue S2, pS31 

    Knowledge of the physiology of folliculogenesis has led to a better understanding of the role of LH activity in this process. This role has been investigated in the setting of ovarian stimulation and several treatment modalities have been proposed. LH activity can be provided in the forms of:...

  • The luteal phase after ovarian stimulation. Kolibianakis, Efstratios M.; Devroey, Paul // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p26 

    Evaluation of the luteal phase after ovarian stimulation presents several difficulties. Until today, it has not been proved that in cycles stimulated with clomiphene citrate/human menopausal gonadotrophins, luteal supplementation with progesterone significantly increases implantation rate. On...

  • Gonadotropin-Releasing Hormone (GnRH) - Antagonist Versus GnRH-Agonist in Ovarian Stimulation of Poor Responders Undergoing IVF. fasouliotis, Sozos J.; Laufer, Neri; Sabbagh-Ehrlich, Shelley; Lewin, Aby; Hurwitz, Arye; Simon, Alex // Journal of Assisted Reproduction & Genetics;Nov2003, Vol. 20 Issue 11, p455 

    Purpose: The objective of this study was to compare the efficacy of GnRH-antagonists to GnRH-agonists in ovarian stimulation of poor responders undergoing IVF. Methods: Retrospective analysis of our data revealed that 56 patients underwent treatment with a GnRH-agonist according to the flare-up...

  • GnRHa to trigger final oocyte maturation: a time to reconsider. Humaidan, P.; Papanikolaou, E. G.; Tarlatzis, B. C. // Human Reproduction;Oct2009, Vol. 24 Issue 10, p2389 

    Recently GnRH antagonist protocols for the prevention of a premature LH surge were introduced, allowing final oocyte maturation to be triggered with a single bolus of a GnRH agonist (GnRHa). GnRHa is as effective as hCG for the induction of ovulation, and apart from the LH surge a FSH surge is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics